Chugai Pharmaceutical Co., Ltd. (CHGCF)
Market Closed
5 Dec, 20:00
OTC PINK OTC PINK Primary $
53. 65
-1.76
-3.18%
$
85.57B Market Cap
- P/E Ratio
164% Div Yield
4,000 Volume
- Eps
$ 55.41
Previous Close Day Range
53.65 53.89
Year Range
32.25 72.3
Want to track CHGCF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 52 days
| CHGCF Chugai Pharmaceutical Co., Ltd. 29 Jan 2026 (In 1 month) | | 71.17 Cons. EPS | - EPS |
| CHGCF Chugai Pharmaceutical Co., Ltd. 24 Oct 2025 | | 73.28 Cons. EPS | 0.46 EPS |
| CHGCF Chugai Pharmaceutical Co., Ltd. 23 Oct 2025 | | - Cons. EPS | - EPS |
| CHGCF Chugai Pharmaceutical Co., Ltd. 24 Jul 2025 | | 72.62 Cons. EPS | 0.41 EPS |
| CHGCF Chugai Pharmaceutical Co., Ltd. 24 Apr 2025 | | - Cons. EPS | - EPS |
| CHGCF Chugai Pharmaceutical Co., Ltd. 30 Jan 2025 | | - Cons. EPS | - EPS |
| CHGCF Chugai Pharmaceutical Co., Ltd. 25 Oct 2024 | | 68.53 Cons. EPS | 66.55 EPS |
| CHGCF Chugai Pharmaceutical Co., Ltd. 25 Jul 2024 | | 52.2 Cons. EPS | 67.98 EPS |
| CHGCF Chugai Pharmaceutical Co., Ltd. 24 Apr 2024 | | 42.91 Cons. EPS | 45.22 EPS |
| CHGCF Chugai Pharmaceutical Co., Ltd. 31 Jan 2024 | | 48.1 Cons. EPS | 55.43 EPS |
| CHGCF Chugai Pharmaceutical Co., Ltd. 24 Oct 2023 | | 53.08 Cons. EPS | 47.15 EPS |
| CHGCF Chugai Pharmaceutical Co., Ltd. 24 Oct 2016 | | 8.17 Cons. EPS | 7.04 EPS |
| CHGCF Chugai Pharmaceutical Co., Ltd. 20 Jul 2016 | | - Cons. EPS | 31.22 EPS |
| CHGCF Chugai Pharmaceutical Co., Ltd. 22 Apr 2016 | | - Cons. EPS | 26.55 EPS |
| CHGCF Chugai Pharmaceutical Co., Ltd. 27 Jan 2016 | | 7.94 Cons. EPS | 8.23 EPS |
| CHGCF Chugai Pharmaceutical Co., Ltd. 22 Oct 2015 | | 9.2 Cons. EPS | 10.69 EPS |
| CHGCF Chugai Pharmaceutical Co., Ltd. 22 Jul 2015 | | 6.07 Cons. EPS | 9.48 EPS |
| CHGCF Chugai Pharmaceutical Co., Ltd. 22 Apr 2015 | | 9.17 Cons. EPS | 8.91 EPS |
| CHGCF Chugai Pharmaceutical Co., Ltd. 27 Jan 2015 | | - Cons. EPS | 0.07 EPS |
| CHGCF Chugai Pharmaceutical Co., Ltd. 23 Oct 2014 | | - Cons. EPS | 0.06 EPS |
| CHGCF Chugai Pharmaceutical Co., Ltd. 30 Sep 2014 | | - Cons. EPS | 0.06 EPS |
| CHGCF Chugai Pharmaceutical Co., Ltd. 30 Jun 2014 | | - Cons. EPS | 0.06 EPS |
| CHGCF Chugai Pharmaceutical Co., Ltd. 31 Mar 2014 | | - Cons. EPS | 0.11 EPS |
| CHGCF Chugai Pharmaceutical Co., Ltd. 31 Dec 2013 | | - Cons. EPS | 0.07 EPS |
| CHGCF Chugai Pharmaceutical Co., Ltd. 30 Sep 2013 | | - Cons. EPS | 0.08 EPS |
| CHGCF Chugai Pharmaceutical Co., Ltd. 30 Jun 2013 | | - Cons. EPS | 0.1 EPS |
| CHGCF Chugai Pharmaceutical Co., Ltd. 31 Mar 2013 | | - Cons. EPS | 0.06 EPS |
CHGCF Earnings Reports FAQ
What is the earnings per share (EPS) for CHGCF?
EPS data for CHGCF is currently not available, as Chugai Pharmaceutical Co., Ltd has not reported recent earnings.
What is the company's earnings growth rate?
Over the past 12 years, the earnings growth rate has been approximately 18.83%, reflecting the CHGCF's performance and OTC PINK market conditions.
When is the next earnings release date?
The next earnings release is expected to be on 2026-01-29, based on the CHGCF's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings were 0.4582 per share, reported on 2025-10-24. For dividend history, visit the CHGCF Dividends page.
What is the price-to-earnings (P/E) ratio?
The price-to-earnings (P/E) ratio is 117.09, calculated based on the most recent stock price of $53.65.
2025 © Marketlog. All Rights Reserved.
